Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.59 USD | +0.95% | +19.88% | +110.77% |
May. 31 | Health Care Stocks Climb On Drug News -- Health Care Roundup | DJ |
May. 31 | Larimar Therapeutics Shares Rise 15% Nomlabofusp Selected for FDA Program | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 612M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -138M | EV / Sales 2024 * | - |
Net cash position 2024 * | 185M | Net cash position 2025 * | 59.3M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.34
x | P/E ratio 2025 * |
-4.46
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Larimar Therapeutics, Inc.
1 day | +0.95% | ||
1 week | +19.88% | ||
Current month | +19.88% | ||
1 month | +21.09% | ||
3 months | -5.98% | ||
6 months | +176.37% | ||
Current year | +110.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 19-12-31 | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 20-05-27 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-05-27 |
Frank Thomas
BRD | Director/Board Member | 54 | 13-12-31 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 23-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 9.59 | +0.95% | 344,927 |
24-06-06 | 9.5 | -3.94% | 504,074 |
24-06-05 | 9.89 | +4.00% | 609,128 |
24-06-04 | 9.51 | +4.05% | 873,904 |
24-06-03 | 9.14 | +14.25% | 1,507,604 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+110.77% | 612M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- LRMR Stock